It may also inhibit the AKT signaling pathway through GPR109A activation, thereby reducing the aerobic glycolysis necessary for CRC cell survival and ultimately impeding the proliferation of cancer cells (152). The gene discussed is HCAR2; the disease is colorectal carcinoma.